ArticleReproductive health2026
Adverse clinical outcomes in patients with good ovarian reserve are linked to a history of cured tuberculosis: a retrospective cohort study.
Article in Reproductive health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThis study examined the effect of prior tuberculosis infection on clinical outcomes in patients with good ovarian reserve.
methodsBased on the POSEIDON criteria, we analyzed data from 5,381 women with normal ovarian reserve who underwent fresh in vitro fertilization (IVF) cycles. Through stratified analysis, we compared the clinical characteristics, IVF laboratory parameters, and clinical outcomes between TB-naïve and TB-cured patients within POSEIDON Group 1 and Group 2.
resultsTB-cured women had significantly lower pregnancy rates (OR 0.766, 95% CI 0.603-0.972) and clinical pregnancy rates (OR 0.710, 95% CI 0.552-0.912) across all ages. In Poseidon group 1, the TB-cured group exhibited an increased risk of ectopic pregnancy (aOR 2.641, 95% CI 1.058-6.595; P = 0.038) and reduced clinical pregnancy rate (77.89% vs. 86.35%, P = 0.007). In Poseidon group 2, the TB-cured group demonstrated impaired ovarian response: a reduction in the number of mature oocytes retrieved (4.94 vs. 6.05; P = 0.007). Among individuals cured of TB in Poseidon group 2, anti-Müllerian hormone (AMH) levels below 1.785 ng/mL provided optimal prediction of insufficient oocyte retrieval (< 5 oocytes; AUC 0.764), outperforming antral follicle count (AFC; AUC 0.557) in predictive accuracy.
conclusionsPrior TB is independently associated with compromised ART success in normo-responders through residual reproductive dysfunction, with young patients experiencing heightened ectopic pregnancy risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.